{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T16:04:22Z","timestamp":1786637062506,"version":"build-2736575974"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"26","license":[{"start":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T00:00:00Z","timestamp":1750982400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,6,27]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>In recent years, with the improvement of people\u2019s living standards, the incidence rate of endometrial cancer shows a rising and younger trend in the world. Early stage endometrial cancer patients have a good prognosis after surgical treatment, but late stage patients have a poor prognosis. Therefore, if biological indicators related to the occurrence and development of endometrial cancer with high sensitivity and specificity can be found, it will provide clinical reference for predicting the prognosis of endometrial cancer and evaluating treatment effectiveness. Vascular endothelial growth factor (VEGF) is a positive regulator of angiogenesis, while microvascular density (MVD) is a quantitative indicator of angiogenesis. This study investigates the expression of VEGF and MVD in endometrial cancer and normal endometrial tissue, and explores their roles in the formation and development of endometrial cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method:<\/jats:title>\n                    <jats:p>Immunohistochemical technique (SP method) was used to detect the expression of VEGF and MVD in paraffin sections of 38 cases of endometrial cancer and 20 cases of normal endometrium. Statistical analysis was conducted using statistical software SPSS 17.0.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The positivity of VEGF in the endometrial cancer group was significantly higher than that in the normal endometrial group. The expression level of MVD in the endometrial cancer group was significantly higher than that in the normal endometrial group. In endometrial cancer, the expression of VEGF is positively correlated with MVD (\n                      <jats:italic toggle=\"yes\">R<\/jats:italic>\n                      \u2005=\u20050.811,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The expression levels of VEGF and MVD are significantly increased in endometrial cancer, and both are positively correlated in endometrial cancer. MVD is related to the surgical pathological staging, lymph node metastasis, and depth of muscle wall infiltration of endometrial cancer, indicating that local neovascularization and rich blood supply play an important role in the occurrence and development of endometrial cancer. VEGF is related to the depth of muscle wall infiltration in endometrial cancer, but not to surgical pathological staging and lymph node metastasis. It is considered that other angiogenic factors besides VEGF play a role in regulating angiogenesis during surgical pathological staging and lymph node metastasis of endometrial cancer.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000042945","type":"journal-article","created":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T15:01:18Z","timestamp":1751295678000},"page":"e42945","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["The expression and relationship of VEGF and MVD in type I endometrial cancer"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-9937-9466","authenticated-orcid":false,"given":"Suning","family":"Bai","sequence":"first","affiliation":[{"name":"Department of Gynecology, Hebei General Hospital, Shijiazhuang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Hebei General Hospital, Shijiazhuang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyun","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Hebei General Hospital, Shijiazhuang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260813","first-page":"302","article-title":"Tumor angiogenesis: review of current applications in tumor prognosis.","volume":"10","author":"Weidner","year":"1993","journal-title":"Semin Diagn Pathol"},{"key":"R2-20260813","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1002\/cncr.32802","article-title":"Annual report to the nation on the status of cancer, part I: National cancer statistics.","volume":"126","author":"Henley","year":"2020","journal-title":"Cancer"},{"key":"R3-20260813","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"R4-20260813","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0140-6736(15)00130-0","article-title":"Endometrial cancer.","volume":"387","author":"Morice","year":"2016","journal-title":"Lancet"},{"key":"R5-20260813","first-page":"7","article-title":"Cancer statistics, 2018.","volume":"68","author":"Siegel","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"R6-20260813","doi-asserted-by":"crossref","first-page":"11211","DOI":"10.2147\/CMAR.S277274","article-title":"The expression of VEGF and CD31 in endometrial lesions and its associations with blood flow parameters of transvaginal 3d power doppler ultrasonography: a preliminary study.","volume":"12","author":"Liu","year":"2020","journal-title":"Cancer Manag Res"},{"key":"R7-20260813","doi-asserted-by":"crossref","first-page":"527","DOI":"10.3389\/fimmu.2018.00527","article-title":"Contribution to tumor angiogenesis from innate immune cells within the tumor microenvironment: implications for immunotherapy.","volume":"9","author":"Albini","year":"2018","journal-title":"Front Immunol"},{"key":"R8-20260813","first-page":"455","article-title":"Vascular endothelial growth factor (VEGF): key factor in normal and pathological angiogenesis.","volume":"59","author":"Melincovici","year":"2018","journal-title":"Rom J Morphol Embryol"},{"key":"R9-20260813","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.3892\/ol.2017.6497","article-title":"Cancer associated fibroblasts: an essential role in the tumor microenvironment.","volume":"14","author":"Tao","year":"2017","journal-title":"Oncol Lett"},{"key":"R10-20260813","doi-asserted-by":"crossref","first-page":"206","DOI":"10.20892\/j.issn.2095-3941.2015.0070","article-title":"Relationship of VEGF\/VEGFR with immune and cancer cells: staggering or forward?","volume":"13","author":"Li","year":"2016","journal-title":"Cancer Biol Med"},{"key":"R11-20260813","first-page":"632","article-title":"Expression and clinical correlation of NGAL and VEGF in endometrial carcinoma.","volume":"22","author":"Xu","year":"2018","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"R12-20260813","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1007\/s00432-020-03225-7","article-title":"Prognostic significance of VEGF and components of the plasminogen activator system in endometrial cancer.","volume":"146","author":"Abbink","year":"2020","journal-title":"J Cancer Res Clin Oncol"},{"key":"R13-20260813","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1006\/gyno.1999.5658","article-title":"VEGF, flt-1, and KDR\/flk-1 as prognostic indicators in endometrial carcinoma.","volume":"76","author":"Fine","year":"2000","journal-title":"Gynecol Oncol"},{"key":"R14-20260813","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.ygyno.2021.04.016","article-title":"Bevacizumab in advanced endometrial cancer.","volume":"161","author":"Rubinstein","year":"2021","journal-title":"Gynecol Oncol"},{"key":"R15-20260813","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s00404-018-4648-1","article-title":"Clinicopathological and prognostic significance of blood microvessel density in endometrial cancer: a meta-analysis and subgroup analysis.","volume":"297","author":"Wang","year":"2018","journal-title":"Arch Gynecol Obstet"},{"key":"R16-20260813","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.3892\/ol.2020.11811","article-title":"Tumor budding index and microvessel density assessment in patients with endometrial cancer: a pilot study.","volume":"20","author":"Kluz","year":"2020","journal-title":"Oncol Lett"},{"key":"R17-20260813","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.1097\/MS9.0000000000000939","article-title":"Relationship of microvascular density on histological and immunohistochemical features in endometrioid adenocarcinomas of the uterus: experimental study.","volume":"85","author":"L\u0443nd\u0456n","year":"2023","journal-title":"Ann Med Surg (Lond)"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000042945","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T15:06:04Z","timestamp":1786633564000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000042945"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,27]]},"references-count":17,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000042945","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,27]]}}}